This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Schering Aktiengesellschaft. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Eberhard Nieschlag: Innovator in Male Contraception
Introduction
Eberhard Nieschlag is a notable inventor based in Muenster, Germany. He has made significant contributions to the field of male contraception, particularly through his innovative formulations. His work has the potential to change the landscape of reproductive health for men.
Latest Patents
Nieschlag holds a patent for a male contraceptive formulation comprising norethisterone. This formulation is designed to effectively suppress spermatogenesis in males. The progestin Norethisterone (NET), along with its derivatives such as Norethisterone acetate and Norethisterone enanthate, can induce oligozoospermia or azoospermia when administered in sufficient doses. Additionally, the formulation may include an androgen, such as a testosterone derivative, particularly testosterone undecanoate, which enhances its effectiveness as a male contraceptive.
Career Highlights
Eberhard Nieschlag has had a distinguished career, working with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His research and innovations have garnered attention and respect within the scientific community.
Collaborations
Nieschlag has collaborated with notable colleagues, including Axel Kamischke and Michael Oettel. Their combined expertise has contributed to the advancement of male contraceptive methods.
Conclusion
Eberhard Nieschlag's work in developing male contraceptive formulations represents a significant advancement in reproductive health. His innovative approach and dedication to research continue to influence the field positively.